Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab

被引：5
作者：
Umezawa, Yoshinori [1 ]
Ito, Keigo [1 ]
Nakagawa, Hidemi [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2013年 / 23卷 / 06期
关键词：
THERAPY;
D O I：
10.1684/ejd.2013.2197
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：910 / 911
页数：3
相关论文
共 50 条
  • [31] New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review
    Matsumoto, Takumi
    Nakamura, Ichiro
    Miura, Ayumi
    Momoyama, Gen
    Ito, Katsumi
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (02) : 271 - 275
  • [32] Successful switching treatment of adalimumab for refractory pyoderma gangrenosum in a patient with rheumatoid arthritis with prior use of tumour necrosis factor inhibitors: A case report and review of the literature
    Ohmura, Shin-ichiro
    Homma, Yoichiro
    Hanai, Shiho
    Otsuki, Yoshiro
    Miyamoto, Toshiaki
    [J]. MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (01) : 9 - 13
  • [33] Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal
    Laires, Pedro A.
    Mesquita, Rui
    Veloso, Luis
    Martins, Ana Paula
    Cernadas, Rui
    Fonseca, Joao Eurico
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [34] Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept
    Horta Barbosa Vieira, Marcella Amaral
    Ramos Saraiva, Maria Isabel
    Leite da Silva, Larissa Karine
    Fraga, Rafael Cavanellas
    Kakizaki, Priscila
    Sakai Valente, Neusa Yuriko
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (08): : 718 - 720
  • [35] Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
    Tanaka, Yoshiya
    Hirata, Shintaro
    Kubo, Satoshi
    Fukuyo, Shunsuke
    Hanami, Kentaro
    Sawamukai, Norifumi
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Yamaoka, Kunihiro
    Sawamura, Fusae
    Saito, Kazuyoshi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 389 - 395
  • [36] Continuous effectiveness and safety after a hospital-wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients
    Brouwer, Rianne
    ten Klooster, Peter M.
    Masselink, Joost B.
    Vonkeman, Harald E.
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (06):
  • [37] Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept
    Arita, Yuki
    Taguchi, Hiroaki
    Kobayashi, Mari
    Tono, Toshihiro
    Ohsone, Yasuo
    Okano, Yutaka
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (06) : 1041 - 1043
  • [38] Sustained drug-free remission and persistent hypogammaglobulinemia in a patient with rheumatoid arthritis three years after discontinuing Rituximab treatment
    Krasselt, M.
    Baerwald, C.
    Seifert, O.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (02): : 190 - 191
  • [39] Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab
    Cornillier, Helene
    Kervarrec, Thibault
    Tabareau-Delalande, Flore
    Mammou, Saloua
    Jonville Bera, Annie-Pierre
    Machet, Laurent
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (06) : 614 - 615
  • [40] Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab
    Abdulkader, Rita
    Dharmapalaiah, Chethana
    Rose, Ginny
    Shand, Lynne M.
    Clunie, Gavin P.
    Watts, Richard A.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 858 - 861
12345